McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

The S&P 500’s health care sector (NYSEARCA:XLV), holding a weightage of 12.12% in the S&P 500 index, saw a fall of 10.2% in ...

The stock's fall snapped a two-day winning streak.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

With a market cap of $74.3 billion, Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services and ...

McKesson (MCK) concluded the recent trading session at $585.08, signifying a +0.57% move from its prior day's close.

McKesson (NYSE:MCK – Get Free Report) had its price objective cut by Citigroup from $713.00 to $677.00 in a research note ...

Miracle Mile Advisors LLC grew its holdings in shares of McKesson Co. (NYSE:MCK – Free Report) by 14.5% in the fourth quarter ...

The transaction enables McKesson to focus capital deployment and prioritize investments in strategic oncology and biopharma ...

BofA lowered the firm’s price target on McKesson (MCK) to $650 from $680 and keeps a Buy rating on the shares. Specialty will remain a key ...

Beyond funding, McKesson Amplify also will provide resources, strategic support and other tools to help state pharmacy associations achieve their local and state advocacy goals in 2025.